A King's College London spin-out company focusing on cardiovascular monitoring has raised £3.2m from new and existing institutional investors and individuals.
LiDCO, a company co-founded in 1991 by Dr David Band, researches, develops, manufactures and sells medical devices primarily for critical-care and high-risk patients who require real-time cardiovascular monitoring while undergoing major surgery, intensive care or cardiology procedures.
The company's products include the LiDCO System and the PulseCO System, which when used together provide a range of data concerning the performance of a patient's heart and blood circulation.
The products have been extensively validated and demonstrated to reduce the hospital stay of high-risk surgery patients by 12 days – saving £4,800 per patient treated. Extrapolated to the whole of the UK this would equate to a saving of £500m per annum for the National Health Service.
The company is listed on the Alternative Investment Market in London.
First seven members join NG’s Great Grid Partnership
Agreed. It is all pretentious posturing and trite branding with no meaning or gravitas. Prepare to be disappointed by all of these greats/grates.